E-viri
Recenzirano
Odprti dostop
-
Vazquez, Michael L; Kaila, Neelu; Strohbach, Joseph W; Trzupek, John D; Brown, Matthew F; Flanagan, Mark E; Mitton-Fry, Mark J; Johnson, Timothy A; TenBrink, Ruth E; Arnold, Eric P; Basak, Arindrajit; Heasley, Steven E; Kwon, Soojin; Langille, Jonathan; Parikh, Mihir D; Griffin, Sarah H; Casavant, Jeffrey M; Duclos, Brian A; Fenwick, Ashley E; Harris, Thomas M; Han, Seungil; Caspers, Nicole; Dowty, Martin E; Yang, Xin; Banker, Mary Ellen; Hegen, Martin; Symanowicz, Peter T; Li, Li; Wang, Lu; Lin, Tsung H; Jussif, Jason; Clark, James D; Telliez, Jean-Baptiste; Robinson, Ralph P; Unwalla, Ray
Journal of medicinal chemistry, 02/2018, Letnik: 61, Številka: 3Journal Article
Janus kinases (JAKs) are intracellular tyrosine kinases that mediate the signaling of numerous cytokines and growth factors involved in the regulation of immunity, inflammation, and hematopoiesis. As JAK1 pairs with JAK2, JAK3, and TYK2, a JAK1-selective inhibitor would be expected to inhibit many cytokines involved in inflammation and immune function while avoiding inhibition of the JAK2 homodimer regulating erythropoietin and thrombopoietin signaling. Our efforts began with tofacitinib, an oral JAK inhibitor approved for the treatment of rheumatoid arthritis. Through modification of the 3-aminopiperidine linker in tofacitinib, we discovered highly selective JAK1 inhibitors with nanomolar potency in a human whole blood assay. Improvements in JAK1 potency and selectivity were achieved via structural modifications suggested by X-ray crystallographic analysis. After demonstrating efficacy in a rat adjuvant-induced arthritis (rAIA) model, PF-04965842 (25) was nominated as a clinical candidate for the treatment of JAK1-mediated autoimmune diseases.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.